BCR-ABL is the oncogenicfusion product of tyrosine kinase ABL1and a highly frequent driver of acute lymphocytic leukemia (ALL) andchronic myeloid leukemia (CML). The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.